Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma.

Head and Neck cancers (HNC) are a heterogeneous group of upper aero-digestive tract cancer and account for 931,922 new cases and 467,125 deaths worldwide. About 90% of these cancers are of squamous cell origin (HNSCC). HNSCC is associated with excessive tobacco and alcohol consumption and infection with oncogenic viruses. Genotyping tumour tissue to guide clinical decision-making is becoming common practice in modern oncology, but in the management of patients with HNSCC, cytopathology or histopathology of tumour tissue remains the mainstream for diagnosis and treatment planning. Due to tumour heterogeneity and the lack of access to tumour due to its anatomical location, alternative methods to evaluate tumour activities are urgently needed. Liquid biopsy approaches can overcome issues such as tumour heterogeneity, which is associated with the analysis of small tissue biopsy. In addition, liquid biopsy offers repeat biopsy sampling, even for patients with tumours with access limitations. Liquid biopsy refers to biomarkers found in body fluids, traditionally blood, that can be sampled to provide clinically valuable information on both the patient and their underlying malignancy. To date, the majority of liquid biopsy research has focused on blood-based biomarkers, such as circulating tumour DNA (ctDNA), circulating tumour cells (CTCs), and circulating microRNA. In this review, we will focus on ctDNA as a biomarker in HNSCC because of its robustness, its presence in many body fluids, adaptability to existing clinical laboratory-based technology platforms, and ease of collection and transportation. We will discuss mechanisms of ctDNA release into circulation, technological advances in the analysis of ctDNA, ctDNA as a biomarker in HNSCC management, and some of the challenges associated with translating ctDNA into clinical and future perspectives. ctDNA provides a minimally invasive method for HNSCC prognosis and disease surveillance and will pave the way in the future for personalized medicine, thereby significantly improving outcomes and reducing healthcare costs.

Nicotine Sensors for Wearable Battery-Free Monitoring of Vaping.

Nicotine, an addictive substance in tobacco products and electronic cigarettes (e-cigs), is recognized for increasing the risk of cardiovascular and respiratory disorders. Careful real-time monitoring of nicotine exposure is critical in alleviating the potential health impacts of not just smokers but also those exposed to second-hand and third-hand smoke. Monitoring of nicotine requires suitable sensing material to detect nicotine selectively and testing under free-living conditions in the standard environment. Here, we experimentally demonstrate a vanadium dioxide (VO2)-based nicotine sensor and explain its conductometric mechanisms with compositional analysis and density functional theory (DFT) calculations. For real-time monitoring of nicotine vapor from e-cigarettes in the air, the sensor is integrated with an epidermal near-field communication (NFC) interface that enables battery-free operation and data transmission to smart electronic devices to record and store sensor data. Collectively, the technique of sensor development and integration expands the use of wearable electronics for real-time monitoring of hazardous elements in the environment and biosignals wirelessly.

Rapid Conductometric Detection of SARS-CoV-2 Proteins and Its Variants Using Molecularly Imprinted Polymer Nanoparticles.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) biosensors have captured more attention than the conventional methodologies for SARS-CoV-2 detection due to having cost-effective platforms and fast detection. However, these reported SARS-CoV-2 biosensors suffer from drawbacks including issues in detection sensitivity, degradation of biomaterials on the sensor's surface, and incapability to reuse the biosensors. To overcome these shortcomings, molecularly imprinted polymer nanoparticles (nanoMIPs) incorporated conductometric biosensor for highly accurate, rapid, and selective detection of two model SARS-CoV-2 proteins: (i) receptor binding domain (RBD) of the spike (S) glycoprotein and (ii) full length trimeric spike protein are introduced. In addition, these biosensors successfully responded to several other SARS-CoV-2 RBD spike protein variants including Alpha, Beta, Gamma, and Delta. Our conductometric biosensor selectively detects the two model proteins and SARS-CoV-2 RBD spike protein variant samples in real-time with sensitivity to a detection limit of 7 pg mL-1 within 10 min of sample incubation. A battery-free, wireless near-field communication (NFC) interface is incorporated with the biosensor for fast and contactless detection of SARS-CoV-2 variants. The smartphone enabled real-time detection and on-screen rapid result for SARS-CoV-2 variants can curve the outbreak due to its ability to alert the user to infection in real time.

Rapid and Selective Biomarker Detection with Conductometric Sensors.

The biomarker detection in human body fluids is crucial as biomarkers are important in diagnosing diseases. Conventional invasive techniques for biomarker detection are associated with infection, tissue damage, and discomfort. Non-invasive devices are an attractive alternative. Here, metal oxide (oxygen-deficient zinc oxide, ZnO) based conductometric sensors with two-terminal electrodes for rapid detection of biomarkers in real-time, are presented. This platform can be engineered for non-invasive, sensitive, and on-demand selective detection of biomarkers based on surface functionalization. The three novelties in this biosensing technique include an on-demand target selection device platform, short (<10 min) incubation times, and real-time monitoring of the biomarker of interest by electrical (resistance change) measurements. Cardiac inflammatory biomarkers interleukin 6 (IL-6) and C-reactive protein (CRP) are used as the model antigens. The devices can detect 100× lower concentration of IL-6 than healthy levels in human saliva and sweat and 1000× and ≈50× lower CRP concentrations than healthy levels in human saliva and sweat, respectively. The devices show high selectivity for IL-6 and CRP antigens when tested with a mixture of biomarkers. This sensor platform can be extended to selective measurements for viruses or DNA screening, which enables a new category of compact and rapid point-of-care medical devices.

Facile displacement of citrate residues from gold nanoparticle surfaces.

The stability of citrate-residues on gold nanoparticles (AuNPs) against ligand displacement has been controversial. Using AuNPs synthesized with deuterated citrate in combination with in-situ surface-enhanced Raman spectroscopic (SERS) analysis, we report that both citrate-residues and solution impurities can be simultaneously adsorbed onto citrate-reduced AuNPs in solution. The citrate-residues can be readily displaced from AuNPs by organosulfur such as organothiols (RS-H), organodisuflide (R-S-S-R), and non-specific ligands including halides and adenine. Control experiments conducted on high-purity gold films sputter-coated onto silicone substrates indicate that air-borne and solvent-borne impurities rapidly contaminate the gold surfaces. Head-to-head comparison of ligand-functionalized AuNPs by in-situ SERS measurements verses those from the ex-situ X-ray photoelectron spectroscopic (XPS) measurements reveal that the impurity deposition can compromise the reliability of ex-situ XPS identification of surface adsorbates on AuNPs in solution. These insights are of general significance to nanoscience research given the broad interest in nanoparticle surface chemistry and popularity of XPS for nanomaterial characterizations.

Direct Observation of Ion Pairing at the Liquid/Solid Interfaces by Surface Enhanced Raman Spectroscopy.

Ion-pairing, the association of oppositely charged ionic species in solution and at liquid/solid interfaces has been proposed as a key factor for a wide range of physicochemical phenomena. However, experimental observations of ion pairing at the ligand/solid interfaces are challenging due to difficulties in differentiating ion species in the electrical double layer from that adsorbed on the solid surfaces. Using surface enhanced Raman spectroscopy in combination with electrolyte washing, we presented herein the first direct experimental evidence of ion pairing, the coadsorption of oppositely charged ionic species onto gold nanoparticles (AuNPs). Ion pairing reduces the electrolyte concentration threshold in inducing AuNP aggregation and enhances the competitiveness of electrolyte over neutral molecules for binding to AuNP surfaces. The methodology and insights provided in this work should be important for understanding electrolyte interfacial interactions with nanoparticles.